Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)

Bayer

Status: Completed

Conditions: Hypertension, Pulmonary

Treatments: Drug: Assigned pulmonary hypertension medication

Study type: Observational

Funder types: Industry

Identifiers

NCT02576002

18515

Details and patient eligibility

About

To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013

Enrollment: 2,691 patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All PAH patients who were in the MarketScan database and who were under age 18 at some time during the years 2010 through 2013

Exclusion criteria

Not applicable

Trial design

2,691 participants in 1 patient group

Pediatric PAH patients

Description:

US pediatric population with PAH in MarketScan database during the period 2010-2013

Treatment:

Drug: Assigned pulmonary hypertension medication